ArticleBiomedical reports2022

Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab.

Takeshi Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.